ARTICLE | Clinical News
Pulmonary delivery of dry powder insulin: Partner Pfizer Inc. began Phase III testing.
November 16, 1998 8:00 AM UTC
Inhale Therapeutic Systems Inc. (INHL), San Carlos, Calif. Product: Pulmonary delivery of dry powder insulin Indication: Treat Types I and II diabetes Status: Partner Pfizer Inc. began Phase III test...